About
Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts.
Annual results
Reported figures, USD · revenue down 39.2% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 1.9B | -2.8B | -145.2% | -2.1B |
| 2024 | 3.2B | -3.6B | -111.3% | -4.1B |
| 2023 | 6.8B | -4.7B | -68.8% | -3.8B |
| 2022 | 18.9B | 8.4B | 44.3% | 4.6B |
| 2021 | 17.7B | 12.2B | 68.8% | 13.3B |
MRNA in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Moderna Inc are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.